Medicine & Life Sciences
Colorectal Neoplasms
100%
Survival
65%
Acute Coronary Syndrome
64%
Colonic Neoplasms
49%
Percutaneous Coronary Intervention
46%
Registries
45%
Cetuximab
31%
Confidence Intervals
30%
Neoplasms
29%
Bevacizumab
28%
Progression-Free Survival
28%
ST Elevation Myocardial Infarction
26%
Non-ST Elevated Myocardial Infarction
26%
Myocardial Infarction
25%
Quality Improvement
24%
Cardiology
22%
Guidelines
21%
Odds Ratio
21%
Leukemia
20%
American Heart Association
17%
Therapeutics
17%
Oxaliplatin
16%
Randomized Controlled Trials
16%
Disease-Free Survival
16%
Biomarkers
16%
Hospital Mortality
15%
Clinical Trials
15%
Adjuvant Chemotherapy
14%
Drug Therapy
14%
Unstable Angina
14%
Capecitabine
14%
regorafenib
13%
Recurrence
13%
Clopidogrel
13%
Circulating Tumor DNA
13%
Irinotecan
13%
Incentive Reimbursement
13%
Mortality
12%
Adenocarcinoma
12%
Fluorouracil
12%
Quality of Health Care
12%
Guideline Adherence
12%
Coronary Artery Bypass
11%
Hemorrhage
10%
Dietary Fats
10%
Troponin
10%
Diet
10%
Mutation
9%
Secondary Prevention
9%
Standard of Care
9%